The Department of Physiology and Pharmacology
Sackler School of Medicine

Dr. Ronit Satchi-Fainaro is a Professor in the Department of Physiology and Pharmacology, Sackler School of Medicine, Tel Aviv University. She joined Tel Aviv University in 2006 after completing her postdoctoral studies at Harvard Medical School and Children’s Hospital Boston where she also holds a Visiting Associate Professor position to date. Since 2014, Prof. Satchi-Fainaro is the chair of the Department of Physiology and Pharmacology, Sackler School of Medicine at Tel Aviv University and serves on the Preclinical Dekanat of the Faculty of Medicine.

Prof. Satchi-Fainaro is a leader in the field of nanomedicine and angiogenesis (cancer and vascular biology). She has major expertise in tumor biology, tumor dormancy, angiogenesis, molecular imaging, non-invasive intravital imaging of animal models, personalized nanomedicines for cancer theranostics (therapy and diagnostics). Throughout, she has maintained an interest in understanding the biological rationale for the design of nanomedicines suitable for transfer into clinical testing. Her multi-disciplinary research laboratory focuses on basic research elucidating the mechanisms underlying the switch from dormancy leading to the discovery of new molecular targets interrupting host-tumor interactions. This approach is followed by the design of highly-selective targeting molecules integrating biology, chemistry, protein engineering, molecular imaging, computational approaches, material sciences and nanotechnology to selectively guide drugs into pathological sites.

Prof. Satchi-Fainaro serves as advisor to several Israeli and International Biotechnology and Pharmaceutical companies, is President of the Israeli Society for Controlled Release, and is on the editorial boards of several biological and chemical journals. She has published more than 70 papers, 12 book chapters, edited 2 books, is named inventor on 30 patents, and was awarded numerous prestigious grants and prizes, among them Fulbright, Rothschild, Wingate, Alon, Young Investigator Award of the European Association for Cancer Research, JULUDAN Prize for the Advancement of Technology in Medicine, and the 2013 Teva Pharmaceutical Industries Founders Award for the Discovery of new molecular mechanisms and targets that would lead to new therapeutic approaches. Her scientific achievements were acknowledged numerous times by inclusion in honorary lists by leading magazines such as “the 50 Most powerful and influential women” list of the Forbes journal, Israel (2014, #13/50), “50 Most influential women of 2011 and 2013” lists of the Globes journal, Israel, 50 Most promising women” list of the Calcalist journal, Israel (2009) and “40 people under the age of 40) list of the The Marker journal, Israel (2008). Recently, she received the European Research Council (ERC) Consolidator Award and the Saban Family Foundation-Melanoma Research Alliance (MRA) Team Science Award.